Table 2.
Compound | Source | Mechanism of Action | Mode of Administration/Study Level | Reference |
---|---|---|---|---|
Aristolochic acids |
Aristolochia indica
Aristolochia sp. Aristolochia odoratissima Aristolochia fordiana Aristolochia radix |
Induction of PLA2 Inhibition of L-amino acid oxidase Anti-lethality |
Injected into the mouse foot pad | [96,97,98,99,118,119,120,121] |
Rosmarinic acid |
Cordia verbenacea
Argusia argentea |
Inhibition of myotoxic activity and PLA2 Anti-hemorrhagic activity |
Injected intramuscularly into the right gastrocnemius muscle of mice In vivo study |
[122,123,124,125] |
Quercetin-3-O-α-L-rhamnopyranoside quinic acid, gallic acid, quercetin, kaempferol, luteolin, ellagic acid, chlorogenic acid |
Euphorbia hirta | Inhibition of PLA2 | In vitro study | [105,126] |
Pinostrobin | Renealmia alpinia | Inhibition of myotoxic activity and PLA2 | Intramuscular injection (inhibition of myotoxic activity) and subcutaneous injection (inhibition of edema-inducing activity) | [81] |
Undisclosed | Azadirachta indica | Inhibition of PLA2 | In vitro study | [127] |
2-hydroxy-4-methoxy benzoic acid | Hemidesmus indicus | Neutralization of venom hemorrhagic activity | Injected intradermally into mice | [128] |
β-sitosterol |
Eclipta prostrata, Humirianthera ampla
Cynanchum paniculatum |
Neutralization of enzymes | In vitro and in vivo studies | [129,130,131] |
8-methoxy coumestrol | Medicago sativa | Inhibition of edema, hemorrhage, and cardio toxicity | Injected intravenously into mice | [132] |
7α-hydroxy-3,13-clerodadiene-16,15:18,19-diolides | Baccharis trimera | Inhibition of metalloproteases | In vitro and in vivo studies | [133] |
CAS # 1260387-36-7 CAS # 2242794-02-9 |
Clematis gouriana | Inhibition of PLA2 | In vitro and computational studies | [111] |
Linearol Isolinearol CAS # 88452-92-0 |
Canistrocarpus cervicornis | Inhibition of induced hemorrhage, hemolysis, and coagulation | Biological assays | [110,114] |
Ellagic acid | Casearia silvestris | Anti-myotoxic and anti-edema | In vivo study | [134,135] |
Resveratrol | Crinum jagus | Neutralization of PLA2, protease, hyaluronidase, L-amino acid oxidase, and 5′-nucleotidase enzyme activities. Anti-myonecrosis and anti-hemorrhagic | Oral and intraperitoneal administration. In vivo study | [136,137] |
Campesterol, β-sitosterol (its glycoside), stigmasterol, catechin, and gallocatechin | Croton urucurana | Anti-hemorrhagic and anti-lethality | In vivo study | [138] |
Rosmarinic acid α-Humulene (−)-trans-Caryophyllene α-Pinene and alloaromadendrene |
Cordia verbenacea | Anti-inflammatory, anti-myotoxic, anti-edematogenic, and anti-PLA2 activity. Anti-edematogenic and reduction of tumor necrosis factor-α (TNFα) Reduction of platelet activating factor, bradykinin, and anti-edematogenic. Anti-inflammatory and anti-edematogenic |
In vivo study | [87,122,139,140] |
Fucoidan | Fucus vesiculosus | Anti-myotoxic activity, anti-PLA2, and anti-necrosis | In vivo study | [141] |
Wedelolactone | Eclipta alba | Anti-hepatotoxic, anti-hypertensive, anti-tumor, anti-PLA2, anti-snake venom, and anti-myotoxic-induced PLA2. | In vivo study | [142,143,144] |
Wedelolactone, sitosterol, and stigmasterol | Eclipta prostrata | Anti-neurotoxic and anti-myotoxic | In vivo study | [145] |
2-hydroxy-4-methoxy-benzoic acid and lupeol acetate | Hemidesmus indicus | Anti-defibrinogenatic, anti-edematogenic, anti-PLA2 activity, anti-necrotic, anti-hemorrhagic, anti-coagulant, lipid peroxidase inhibition, superoxide dismutase activity, antiserum action potentiation, anti-lethality, anti-cardiotoxic, and anti-neurotoxic | In vivo study | [78,79,128,146] |
Pentagalloyl glucopyranose | Mangifera indica | Anti-hemorrhagic, anti-dermonecrotic, and enzymatic activities. Inhibition of protease, hyalunoridase, fibrinogenolytic, procoagulant, anti-edematogenic, anti-ATPase, and alkaline phosphatase |
In vivo study | [60,83] |
Gallic acid | Musa paradisiaca | Anti-PLA2, anti-myotoxic, anti-hemorrhagic, and anti-lethality | In vivo study | [109,147] |
Alternamin | Murraya alternans | Anti-hemorrhagic | In vivo study | [148] |
Macrolobins A and B | Pentaclethra macroloba | Anti-proteolytic and anti-hemorrhagic, metalloprotease inhibitors | In vitro and in vivo studies | [112] |
4-Nerolidyl-catechol |
Piper umbellatum and
Piper peltatum |
Anti-myotoxic, anti-PLA2, anti-serineprotease, and anti-edematogenic | In vivo study | [42] |
Solanidane | Solanum campaniforme | Hemorrhagic inhibitor, necrotizing, and myotoxicity effects | In vivo study | [149] |
12-methoxy-4-methyl-voachalotine | Tabernaemontana catharinensis | Inhibited lethality | In vivo study | [116,117] |
Whitania Somnifera Glycoprotein (WSG) | Withania somnifera | Anti-edematogenic | In vivo study | [150] |
β-sitosterol, quercetin-3-O-glucopyranoside, and kaempferol-3-O-glucopyranoside | Morus nigra | Anti-inflammatory and antinociceptive effects | In vivo study | [151] |
2-hydroxy-3-methoxy benzaldehyde | Janakia arayalpathra | Anti-PLA2 | In vitro study | [92] |
Marmin | Aegle marmelos | Anti-snake venom | In vivo study | [85] |
Cabenegrins AI and A-II | Annona coriaceae | Anti-snake venom | In vitro and in vivo studies | [107] |
Boc-5 and Boc-10 (sulfated galactans) | Botryocladia occidentalis | Anti-edematogenic, anti-myotoxic, and anti-neurotoxic | In vivo study | [152] |
Edunol | Brongniartia podalyrioides | Protective effect against Bothrops atrox venom | In vivo study | [45] |
Dolastane | Canistrocarpus cervicornis | Inhibition of induced hemorrhaging, hemolysis, and coagulation | In vitro and in vivo studies | [116] |
Manoalide | Luffariella variabilis | Inhibition of extracellular PLA2 activity of cobras | In vitro study | [153] |
DM64 (acidic glycoprotein) | Didelphis marsupialis | PLA2 inhibitor and prevention of myofiber breakdown caused by myotoxins I (Asp49) and II (Lys49) of B. asper venom | In vitro and in vivo studies | [154] |
Aristolochic acid (8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid) Caffeic acid (3-(3,4-dihydroxyphenyl)-2-propenoic acid) |
Aristolochia species
Vernonia condensate |
Inhibition of piratoxin-1 (PrTX-1), a Lys49-PLA2 isolated from Bothrops pirajai venom Inhibition of PrTX-1 and antidote activity against B. jararaca venom |
Oral or parenteral administration In vitro and in vivo studies |
[85,119] [121] |